[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 8, Issue 2 (4-2006) ::
J Babol Univ Med Sci. 2006; Volume 8 Back to browse issues page
Intermediate dose and course Furazolidone and Amoxicillin versus Metronidazole and Amoxicillin in quadruple therapy for eradication of Helicobacter Pylori
M Kashi Fard * , H Taheri , M Barz Kar
Abstract:   (53154 Views)
BACKGROUND AND OBJECTIVE: H. pylori eradication has been known as an effective measure in the treatment of peptic ulcer disease (PUD), chronic gastritis and gastric malt lymphoma. Furazolidone has recently shown promising efficacy in H. Pylori eradication and has replaced metronidazole in different eradication regimens. The aim of this study was to investigate the efficacy of two quadruple therapies based on furazolidone or metronidazole in the eradication of H. Pylori in Babol.
METHODS: This interventional study was performed on 103 patients with dyspepsia and endoscopic diagnosis of H. pylori infection. H. pylori status was assessed by histologic examination of biopsy specimens and rapid urease test (RUT). Patients were randomly assigned to one of the two treatment groups: ABRM (amoxicillin 500 mg tid, bismuth subcitrate 120 mg tid, ranitidine 150 mg bid and metronidazole 250 mg tid) and ABRF (with the same regimens but furazolidone 100 mg tid was administered in stead of metronidazole 250 mg tid). All antibiotics were taken for 10 days, but BR for 20 days. The endoscopy was repeated 4 weeks after the cessation of antibiotics. The efficacy of eradication was assessed by the histologic examinations and RUT.
FINDINGS: Of 103 patients, 96 (%96.1) completed treatment. Forty-six patients with mean age of 42 years (range: 20-75 years) and 50 with mean age of 40 years (range: 18-71 years) were treated with ABRM and ABRF, respectively. Clinical manifestations were the same in both groups. The per-protocol eradication rates were 54.3% and 60% for the ABRM and ABRF groups, respectively (p= 0.362).
CONCLUSION: This study show that both quadruple metronidazole and furazolidone have equal effect on the eradication of H. pylori.
Keywords: Helicobacter pylori, Dyspepsia, Metronidazole, Furazolidone
Full-Text [PDF 299 kb]   (3852 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/1 | Published: 2014/06/1


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kashi Fard M, Taheri H, Barz Kar M. Intermediate dose and course Furazolidone and Amoxicillin versus Metronidazole and Amoxicillin in quadruple therapy for eradication of Helicobacter Pylori. J Babol Univ Med Sci 2006; 8 (2) :24-31
URL: http://jbums.org/article-1-2551-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 8, Issue 2 (4-2006) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.07 seconds with 43 queries by YEKTAWEB 4645